Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study

OBJECTIVES: To assess the safety and tolerability as well as antiretroviral impact of ABX464, an oral investigational drug with a novel mechanism of HIV-1 inhibition (ClinicalTrials.gov NCT02735863). METHODS: Randomised, double-blind, placebo-controlled, Phase IIa study in individuals living with HI...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutsaert, Sofie, Steens, Jean-Marc, Gineste, Paul, Cole, Basiel, Kint, Sam, Barrett, P Noel, Tazi, Jamal, Scherrer, Didier, Ehrlich, Hartmut J, Vandekerckhove, Linos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362909/
https://www.ncbi.nlm.nih.gov/pubmed/30800421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362909/
https://www.ncbi.nlm.nih.gov/pubmed/30800421

Ejemplares similares